DEVELOPMENT OF A PLATFORM FOR IDENTIFICATION OF MUTANOA AND PERSONALISED VACCINATION IN CANCER PATIENTS — PRCIVEX_2535 (Q2019366): Difference between revisions
Jump to navigation
Jump to search
(Removed claim: co-financing rate (P837): 74.20530897783384 percent) |
(Changed an Item) |
||||||
| Property / co-financing rate | |||||||
74.21 percent
| |||||||
| Property / co-financing rate: 74.21 percent / rank | |||||||
Normal rank | |||||||
Revision as of 03:42, 20 March 2020
Project in Italy financed by DG Regio
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | DEVELOPMENT OF A PLATFORM FOR IDENTIFICATION OF MUTANOA AND PERSONALISED VACCINATION IN CANCER PATIENTS — PRCIVEX_2535 |
Project in Italy financed by DG Regio |
Statements
986,675.87 Euro
0 references
1,329,656.71 Euro
0 references
74.21 percent
0 references
1 November 2016
0 references
31 December 2018
0 references
NOUSCOM SOCIETA' A RESPONSABILITA' LIMITATA
0 references
BIOTECNOLOGIE (Italian)
0 references
Identifiers
B88I17000390008
0 references